Henry Schein, a provider of healthcare solutions for office-based practitioners, has announced the completion of its acquisition of Acentus, a Tampa, Florida-based medical supplier specializing in Continuous Glucose Monitors (CGMs). Acentus generates annual revenue of approximately $35 million, and Henry Schein anticipates the transaction will be neutral to its 2025 non-GAAP earnings per share and accretive in subsequent years. This acquisition strengthens Henry Schein’s position in the home medical supply market by delivering CGM products directly to patients' homes, a move aimed at enhancing customer service and supporting growth.
The acquisition builds on Henry Schein’s previous purchases of Prism Medical Products in 2021 and Shield Healthcare and Mini Pharmacy in 2023, furthering its strategic focus on homecare solutions. With this addition, the company’s homecare medical products platform will have an annual revenue exceeding $350 million. Acentus Founders Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia will join Henry Schein, contributing their expertise in health care and product categories. Henry Schein, which serves more than 1 million customers through its extensive distribution network, continues to expand its range of solutions that help improve clinical outcomes and operational efficiency for healthcare providers worldwide.
